Back to Ovarian Cancer
NCT06534424
NCT06534424
Who may be able to join
Who might be able to join this trial:
- You have had genetic counseling and testing for BRCA1 and/or BRCA2 gene mutations at an approved, certified laboratory
- Your genetic test results showed that you carry a known harmful gene mutation
- Your test results were shared with you within the last 3 weeks
- Your medical records are available for the research team to review
- You are able to provide a DNA sample, either through a blood draw or a mouthwash sample
- You have access to a telephone and a computer or other device that can connect to the internet
- You have not yet had surgery to remove both breasts or both ovaries and fallopian tubes as a preventive measure
Who may not be able to join:
- You have already had surgery to remove both breasts as a preventive measure
- You have already had surgery to remove both ovaries and fallopian tubes as a preventive measure
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Status
Completed
Phase
Not Applicable
Sponsor
Ohio State University Comprehensive Cancer Center
Registry
clinicaltrials_gov
Start date
1 January 2018
Est. completion
30 September 2023
Where this trial is recruiting
🇺🇸 United States
Primary endpoints
Decisional conflict Regarding Cancer Risk Management
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.